These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8260238)

  • 1. Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates.
    Remvikos Y; Jouve M; Beuzeboc P; Viehl P; Magdelenat H; Pouillart P
    Eur J Cancer; 1993; 29A(13):1843-8. PubMed ID: 8260238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy.
    Remvikos Y; Mosseri V; Zajdela A; Fourquet A; Durand JC; Pouillart P; Magdelénat H
    Ann N Y Acad Sci; 1993 Nov; 698():193-203. PubMed ID: 8279757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in biological markers after primary chemotherapy for breast cancers.
    Daidone MG; Silvestrini R; Luisi A; Mastore M; Benini E; Veneroni S; Brambilla C; Ferrari L; Greco M; Andreola S
    Int J Cancer; 1995 May; 61(3):301-5. PubMed ID: 7729938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of cytology for the efficacy of chemotherapy in breast cancers].
    Briffod M
    Arch Anat Cytol Pathol; 1995; 43(1-2):19-27. PubMed ID: 7794023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer.
    O'Reilly SM; Camplejohn RS; Rubens RD; Richards MA
    Eur J Cancer; 1992; 28(2-3):681-3. PubMed ID: 1591092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation.
    Remvikos Y; Vielh P; Padoy E; Benyahia B; Voillemot N; Magdelénat H
    Br J Cancer; 1991 Sep; 64(3):501-7. PubMed ID: 1911191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis.
    Briffod M; Spyratos F; Hacène K; Tubiana-Hulin M; Pallud C; Gilles F; Rouëssé J
    Cytometry; 1992; 13(3):250-8. PubMed ID: 1576891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer.
    Muss HB; Thor AD; Berry DA; Kute T; Liu ET; Koerner F; Cirrincione CT; Budman DR; Wood WC; Barcos M
    N Engl J Med; 1994 May; 330(18):1260-6. PubMed ID: 7908410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
    van Ramshorst MS; van der Voort A; van Werkhoven ED; Mandjes IA; Kemper I; Dezentjé VO; Oving IM; Honkoop AH; Tick LW; van de Wouw AJ; Mandigers CM; van Warmerdam LJ; Wesseling J; Vrancken Peeters MT; Linn SC; Sonke GS;
    Lancet Oncol; 2018 Dec; 19(12):1630-1640. PubMed ID: 30413379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of five cell cycle analysis models applied to 1414 flow cytometric DNA histograms of fresh frozen breast cancer.
    Bergers E; van Diest PJ; Baak JP
    Cytometry; 1997 Feb; 30(1):54-60. PubMed ID: 9056743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA-analysis of cells obtained with fine needle aspiration biopsy of the breast.
    Niezabitowski A; Lackowska B; Gruchala A; Ryś J; Jaszcz A; Szklarski W; Wasilewska A; Herman K
    Gen Diagn Pathol; 1996 Jun; 142(1):33-9. PubMed ID: 8793484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy of breast cancer.
    Garces CA; Cance WG
    Am Surg; 2004 Jul; 70(7):565-9. PubMed ID: 15279176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.
    Chang J; Ormerod M; Powles TJ; Allred DC; Ashley SE; Dowsett M
    Cancer; 2000 Dec; 89(11):2145-52. PubMed ID: 11147583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up.
    Spyratos F; Briffod M; Tubiana-Hulin M; Andrieu C; Mayras C; Pallud C; Lasry S; Rouëssé J
    Cancer; 1992 Jan; 69(2):470-5. PubMed ID: 1728376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of sequential fine-needle aspiration biopsy with flow cytometry to monitor radiation induced changes in breast carcinoma.
    Zbieranowski I; Le Riche JC; Jackson SM; Olivotto I
    Anal Cell Pathol; 1992 Jan; 4(1):13-24. PubMed ID: 1370908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
    Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
    Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(2):366-71. PubMed ID: 23818347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy.
    Remvikos Y; Beuzeboc P; Zajdela A; Voillemot N; Magdelénat H; Pouillart P
    J Natl Cancer Inst; 1989 Sep; 81(18):1383-7. PubMed ID: 2778823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study.
    Chintamani ; Singhal V; Singh JP; Lyall A; Saxena S; Bansal A
    BMC Cancer; 2004 Aug; 4():48. PubMed ID: 15310398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.